Age differences in sarcoidosis patients with posterior ocular lesions.

scientific article published on 19 December 2013

Age differences in sarcoidosis patients with posterior ocular lesions. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/09273948.2013.855796
P698PubMed publication ID24354362

P50authorKazuichi MaruyamaQ47149002
P2093author name stringShigeru Kinoshita
Toru Nakazawa
Kenji Nagata
Manabu Mochizuki
Sunao Sugita
Atsuko Ishizuka
Yukiko Terada
Urara Fukuchi
P2860cites workSarcoidosisQ21202958
Clinical features of sarcoidosis in relation to HLA distribution and HLA-DRB3 genotyping by PCR-RFLPQ24563141
Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosisQ33212651
Ocular involvement in sarcoidosisQ33803813
A case control etiologic study of sarcoidosis: environmental and occupational risk factorsQ33981111
International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS).Q37544507
A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study GroupQ41213721
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cellsQ42677798
Glucocorticoid-induced osteoporosis in patients with sarcoidosisQ44288850
Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosisQ46549629
Referral patterns of uveitis in a tertiary eye care center.Q51034605
Frequency and clinical features of intraocular inflammation in Tokyo.Q51813919
Prognosticators for visual outcome in sarcoid uveitis.Q52292819
SarcoidosisQ54152750
P433issue4
P304page(s)257-262
P577publication date2013-12-19
P1433published inOcular Immunology and InflammationQ15760486
P1476titleAge differences in sarcoidosis patients with posterior ocular lesions
P478volume22

Search more.